Rama Krishna Kancha, Nikolas von Bubnoff, Cornelius Miething, Christian Peschel, Katharina S. Götze, Justus Duyster. Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation. haematol [Internet]. 2008Oct.31 [cited 2024Apr.27];93(11):1718-22. Available from: https://haematologica.org/article/view/5077